Víctor González Herrera Net Worth: How to Verify and Estimate

Víctor González Herrera is a Mexican business executive born September 15, 1987, in Mexico City. He is the son of Víctor González Torres (the founder of Farmacias Similares, popularly known as 'Doctor Simi'), and he currently serves as CEO of Farmacias Similares and executive president of Grupo Por Un País Mejor. The most widely cited net worth estimate for him sits around $400 million USD, but that figure comes from aggregator sites with no audited financial documentation behind it, so treat it as a ballpark rather than a confirmed number.

Which Víctor González Herrera (and which Víctor González Torres) are we talking about?

This is genuinely the first thing you need to nail down, because the name 'Víctor González' is one of the most common Spanish-language name combinations in Mexico. Wikipedia even maintains a disambiguation page for 'Víctor González' because there are so many notable people sharing it. The two names that cause the most confusion in search results are Víctor González Herrera and Víctor González Torres, and they are not the same person. They are father and son.

• Víctor González Torres: the founder of Farmacias Similares, born in an earlier generation, known publicly as 'Doctor Simi,' and a former political candidate (his 2006 presidential candidacy appears in TEPJF electoral court records). He created Grupo Por Un País Mejor and built the pharmacy empire from the ground up.
• Víctor González Herrera: the son, born September 15, 1987, who took over operational leadership and is now CEO of Farmacias Similares and executive president of the group. The 'Herrera' maternal surname is the key distinguisher.
• The easiest disambiguation rule: if the source mentions 'Doctor Simi' as a personal nickname or refers to a founding generation, it's the father (Torres). If the source mentions a young executive leading the current expansion phase, it's the son (Herrera).

Sources including Forbes México, Infobae, ACI Prensa, El Universal, El Economista, and MERCO's 2025 leadership ranking all confirm Víctor González Herrera as the active executive figure at Farmacias Similares today. When you're reading about net worth, always check which generation is referenced. When people search for Victor Martinez bodybuilder net worth, the same credibility check applies because net worth numbers are often based on assumptions instead of audited records. To make sure you are looking at the right person, this article also explains what to trust when searching for Victor Ortiz's boxer net worth Victor Ortiz boxer net worth. If you specifically want the latest figure for victor fontanez net worth, apply the same credibility filter and identity checks described here for Farmacias Similares executives Victor Ortiz boxer net worth. Mixing them up leads to wildly wrong wealth estimates being attached to the wrong person.

What 'net worth' actually means here (and what it doesn't)

Net worth, at its most basic, is total assets minus total liabilities. For a private business executive like Víctor González Herrera, the practical problem is that almost none of those inputs are public. There are no SEC filings, no mandatory public wealth disclosures, and no stock-exchange-level transparency because Farmacias Similares is a privately held company. What you're left with as a researcher is indirect inference rather than direct measurement.

The honest position is this: no primary financial document, audited report, or official patrimonial declaration for Víctor González Herrera has surfaced in publicly available sources as of April 2026. Any specific figure you see on net worth aggregator sites is an estimate built on assumptions, not verified data.

How to research this properly using public sources

There is a practical research path here even without audited filings. It takes a few steps, but it gets you to a defensible range rather than a borrowed guess from a content farm.

1. Confirm identity first. Cross-check full name, birth date (September 15, 1987), role (CEO of Farmacias Similares / Grupo Por Un País Mejor), and family relationship (son of Víctor González Torres). Sources: Wikipedia, Infobae, Forbes México, ACI Prensa, MERCO.
2. Estimate company scale. Farmacias Similares operates thousands of locations across Mexico and is expanding internationally. Look for any available revenue reporting in Mexican business media (El Economista, El Financiero, Expansión) to get a sense of enterprise value.
3. Apply ownership fraction logic. If the González family controls a significant stake in the company, even a conservative valuation of the enterprise (revenue multiples are standard for pharmacy retail) gives you a wealth proxy. This is indirect but grounded.
4. Check for real estate or investment disclosures. Mexican public registry records (Registro Público de la Propiedad) can sometimes surface significant real estate holdings under an individual's name, though this requires direct search tools.
5. Review any political or regulatory filings. Because the father (Víctor González Torres) was a political candidate, some financial disclosures may exist in TEPJF or INE records for him. The son has not held public office, so this route is less productive for Herrera specifically.
6. Cross-reference aggregator sites but treat them as starting points, not endpoints. Sites like Sharks Net Worth report $400 million for Víctor González Herrera. Use that as a hypothesis to test, not a fact to cite.
7. Look for recent media events that signal wealth movement: new store openings, international expansion announcements, foundation activities, or legal proceedings. El Universal and El Economista are good beats to monitor.

Current best estimate and the honest range

The most specific figure in circulation is $400 million USD, sourced from Sharks Net Worth. For context, People AI estimates Víctor González Torres (the father) at roughly $125 million for 2026, though that site's methodology is based on social signals rather than financial analysis. The fact that the son is estimated higher than the father on some sites likely reflects either different methodologies or the son's more prominent executive profile in recent coverage.

A more defensible range, working from what we know about Farmacias Similares as a business, places Víctor González Herrera's personal net worth somewhere between $150 million and $500 million USD. The lower bound reflects a conservative ownership stake in a major private pharmacy chain with thousands of locations. The upper bound reflects a more aggressive company valuation multiplied by a controlling family stake. Without direct financial disclosures, this is the honest spread.

The &lt;a data-article-id=&quot;FBB1FEC1-F685-4EFA-AF0A-DA6766269796&quot;&gt;$400 million figure</a> sits within that range and isn't implausible, but it should be read as a single data point from an unaudited aggregator, not a verified fact. If you need to cite a number, use the range and note the source limitation.

What moves the number over time

Net worth for a private company executive like Víctor González Herrera is not static. Several forces can push it significantly in either direction, sometimes within a single year.

• Business expansion or contraction: Farmacias Similares' international growth (El Economista reported on this in 2024) directly increases enterprise value and therefore ownership stake value. New country entries or major domestic store openings are wealth-positive signals.
• Leadership transitions: As the son transitions from operational executive to recognized controlling figure, market perception of the brand under his leadership can shift company valuation.
• Regulatory and tax environment: Mexico's SAT oversight of the multiple foundations linked to Grupo Por Un País Mejor means any regulatory change around charitable structures could affect net financial positioning.
• Legal exposure: Any litigation involving the company or family (similar to the father's past legal and political controversies) could reduce asset values or generate liabilities.
• Investment performance: If family wealth is diversified beyond Farmacias Similares into real estate, financial instruments, or other businesses, those performance outcomes affect total net worth independently of the pharmacy chain.
• Currency effects: Since Farmacias Similares operates primarily in Mexican pesos but net worth estimates are often converted to USD, peso/dollar exchange rate movements change the USD figure even if peso-denominated wealth stays flat.

Source transparency: what to trust and what to question

When you're evaluating any net worth figure for Víctor González Herrera, run it through a quick credibility filter. This is the same approach we use on this site: separate what's identity-confirmed from what's financially documented.

To verify any figure yourself, the most reliable path is to start with Mexican business media archives (El Economista, Expansión, El Financiero), then cross-reference with Registro Público de la Propiedad for any major real estate, and finally check SAT-registered entity names for any public corporate filings. You won't get a single clean number, but you'll build a defensible estimate rather than laundering an aggregator's guess.

Common mix-ups and how to avoid them

Beyond the father-son confusion already covered, there are a few other disambiguation traps worth knowing. Wikipedia's 'Víctor González' disambiguation page lists multiple individuals, and search engines don't always surface the right one depending on how you phrase the query.

• Víctor González Torres vs. Víctor González Herrera: The most common mix-up. Father is the founder and 'Doctor Simi' figure; son is the current CEO. Use the second surname to tell them apart immediately.
• Other 'Víctor González' figures: There are unrelated athletes, politicians, and entertainers with similar names across Mexico and Latin America. If a result doesn't mention Farmacias Similares, Grupo Por Un País Mejor, or the Dr. Simi brand, it's a different person entirely.
• Net worth figures attributed to the wrong generation: Some sites may list the father's estimated wealth under the son's name or vice versa. Always check which person the figure actually references by confirming the birth year (1987 for the son) and role description.
• Confusing brand wealth with personal wealth: Farmacias Similares and Dr. Simi are brand assets, not personal bank accounts. Brand valuation figures sometimes get conflated with personal net worth in less rigorous coverage.
• Name variants in English-language sources: Some international sources write 'Victor Gonzalez Herrera' without accents, and search algorithms may not always connect these to the correct Spanish-language biography.

This kind of disambiguation work is standard territory for anyone researching notable Víctors. Similar care is needed when researching figures like Victor Manuelle or Victor Antonio, where multiple people share elements of the same name and content gets attributed to the wrong individual across different industries and geographies. If you're also comparing figures like victor manuelle net worth, use the same identity-checking mindset because name collisions can easily attach the wrong wealth estimate to the wrong person. If you see claims about Victor Antonio net worth, double-check that the identity matches the specific person you mean before trusting any number.

Your next steps to get the most accurate figure

If you walked away from this article needing one thing, it's a verified identity combined with a ranged estimate rather than a single borrowed number. Here is how to move forward practically.

1. Lock in identity: confirm you're looking at Víctor González Herrera, born September 15, 1987, CEO of Farmacias Similares, son of Víctor González Torres. If a source doesn't match these markers, it's a different person.
2. Use $150M to $500M USD as your working range, with $400M as the most commonly cited single-point estimate. Note that the $400M figure comes from an unaudited aggregator (Sharks Net Worth) and has no primary financial documentation.
3. Monitor Forbes México, El Economista, and Expansión for business developments that signal wealth movement, especially international expansion news or major strategic shifts at Farmacias Similares.
4. If you need a more precise figure for any formal purpose, consult a Mexican financial research service or business intelligence database that tracks private company valuations directly.
5. Do not use People AI or similar social-signal-based trackers as financial sources; their methodology is not grounded in balance sheets or earnings reports.
6. Check back regularly. Net worth for a private executive in an actively expanding company can shift meaningfully year over year, and any figure you see today may be outdated within 12 months.